Menu
GWAS Study

Germline variants at SOHLH2 influence multiple myeloma risk.

Duran-Lozano L, Thorleifsson G, Lopez de Lapuente Portilla A et al.

33875642 PubMed ID
GWAS Study Type
427613 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

DL
Duran-Lozano L
TG
Thorleifsson G
LD
Lopez de Lapuente Portilla A
NA
Niroula A
WM
Went M
TM
Thodberg M
PM
Pertesi M
AR
Ajore R
CC
Cafaro C
OP
Olason PI
SL
Stefansdottir L
BW
Bragi Walters G
HG
Halldorsson GH
TI
Turesson I
KM
Kaiser MF
WN
Weinhold N
AN
Abildgaard N
AN
Andersen NF
MU
Mellqvist UH
WA
Waage A
JA
Juul-Vangsted A
TU
Thorsteinsdottir U
HM
Hansson M
HR
Houlston R
RT
Rafnar T
SK
Stefansson K
NB
Nilsson B
Chapter II

Abstract

Summary of the research findings

Multiple myeloma (MM) is caused by the uncontrolled, clonal expansion of plasma cells. While there is epidemiological evidence for inherited susceptibility, the molecular basis remains incompletely understood. We report a genome-wide association study totalling 5,320 cases and 422,289 controls from four Nordic populations, and find a novel MM risk variant at SOHLH2 at 13q13.3 (risk allele frequency = 3.5%; odds ratio = 1.38; P = 2.2 × 10-14). This gene encodes a transcription factor involved in gametogenesis that is normally only weakly expressed in plasma cells. The association is represented by 14 variants in linkage disequilibrium. Among these, rs75712673 maps to a genomic region with open chromatin in plasma cells, and upregulates SOHLH2 in this cell type. Moreover, rs75712673 influences transcriptional activity in luciferase assays, and shows a chromatin looping interaction with the SOHLH2 promoter. Our work provides novel insight into MM susceptibility.

4,376 European ancestry multiple myeloma cases, 944 European ancestry monoclonal gammopathy of undetermined significance cases, 422,293 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

427613
Total Participants
GWAS
Study Type
Yes
Replicated
5,598 European ancestry cases, 15,261 European ancestry controls
Replication Participants
European
Ancestry
Denmark, Iceland, Norway, Sweden, Netherlands, Germany, U.K., U.S.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.